Taisho Pharmaceutical Holdings Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd. is a registered legal entity registered in Japan under 1010001237861, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 21 August 2023 and lists its registered address as Toshima Ward, Japan. 5 shareholders are on record for Taisho Pharmaceutical Holdings Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 1 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of Taisho Pharmaceutical Holdings Co., Ltd.
Five shareholders are currently on record for Taisho Pharmaceutical Holdings Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 26.2% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 15.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 26.2% | National Tax Agency — Corporate Number Publication Site | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 15.4% | National Tax Agency — Corporate Number Publication Site | |
| Goldman Sachs International Small Cap Insights Fund | 14% | National Tax Agency — Corporate Number Publication Site | |
| iShares Core MSCI EAFE ETF | 9.6% | National Tax Agency — Corporate Number Publication Site | |
| Brandes International Equity Fund | 8.4% | National Tax Agency — Corporate Number Publication Site |
Officers
5
Directors and officers of Taisho Pharmaceutical Holdings Co., Ltd.
The Ceo & Representative Director of Taisho Pharmaceutical Holdings Co., Ltd. currently on record is Akira Uehara; five officers are currently on record for Taisho Pharmaceutical Holdings Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Taisho Pharmaceutical Holdings Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 6 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Taisho Pharmaceutical Holdings Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- CUBE, K.K. (Japan)
- TAISHO SEIYAKU F M K.K. (Japan)
- TAISHO PHARMACEUTICAL CO., LTD. (Japan)
- Vitacilina Corporation of America (United States)
- BIOFERMIN PHARMACEUTICAL CO.,LTD. (Japan)
- TAISHO PHARMA CO., LTD. (Japan)
Data availability
Those 6 subsidiaries span Japan, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Taisho Pharmaceutical Holdings Co., Ltd.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Taisho Pharmaceutical Holdings Co., Ltd.?
Five shareholders are currently on record for Taisho Pharmaceutical Holdings Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 26.2% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 15.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Taisho Pharmaceutical Holdings Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Taisho Pharmaceutical Holdings Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Taisho Pharmaceutical Holdings Co., Ltd. have on record?
5 shareholders are shown on record for Taisho Pharmaceutical Holdings Co., Ltd.. The register reports 10 in total; only the top 5 by holding are shown here.
What is Taisho Pharmaceutical Holdings Co., Ltd.'s company registration number?
Taisho Pharmaceutical Holdings Co., Ltd.'s registration number is 1010001237861, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.
Is Taisho Pharmaceutical Holdings Co., Ltd. still an active company?
Taisho Pharmaceutical Holdings Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.
When was Taisho Pharmaceutical Holdings Co., Ltd. incorporated?
Taisho Pharmaceutical Holdings Co., Ltd. was incorporated on 21 August 2023, according to National Tax Agency — Corporate Number Publication Site.
What is Taisho Pharmaceutical Holdings Co., Ltd.'s registered address?
The registered address on file for Taisho Pharmaceutical Holdings Co., Ltd. is Toshima Ward, Japan.
Who are the officers/directors of Taisho Pharmaceutical Holdings Co., Ltd.?
The Ceo & Representative Director of Taisho Pharmaceutical Holdings Co., Ltd. currently on record is Akira Uehara; five officers are currently on record for Taisho Pharmaceutical Holdings Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Taisho Pharmaceutical Holdings Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Taisho Pharmaceutical Holdings Co., Ltd. have a parent company or subsidiaries?
Taisho Pharmaceutical Holdings Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 2 jurisdictions. Those 6 subsidiaries span Japan, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Taisho Pharmaceutical Holdings Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Taisho Pharmaceutical Holdings Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Taisho Pharmaceutical Holdings Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Taisho Pharmaceutical Holdings Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 1 October 2026.